Literature DB >> 12229233

Strategic thinking in eye trauma management.

Ferenc Kuhn1.   

Abstract

Treating patients with serious eye injuries is not only a difficult, but also occasionally frustrating process. Mastering the details of the management of individual tissue lesions allows one to "see the tree" but does not provide vision of the entire forest. To develop a comprehensive understanding that leads to strategic thinking before making actual reconstruction efforts, the surgeon should follow a fairly rigorous thought process to find the best possible management option for the particular injury (Fig. 1). His or her suggestion, as well as detailed information on other options, should be discussed with the patient, and the decision regarding how to proceed is best if it meets the approval of, and is supported by, the patient. Such an approach has the highest chance of rewarding the patient and the treating physician.

Entities:  

Mesh:

Year:  2002        PMID: 12229233     DOI: 10.1016/s0896-1549(02)00009-3

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN: 0896-1549


  3 in total

1.  Ocular trauma treated with pars plana vitrectomy: early outcome report.

Authors:  Mohammad Reza Mansouri; Seyed Ali Tabatabaei; Mohammad Soleimani; Mohammad Yaser Kiarudi; Saber Molaei; Mehdi Rouzbahani; Meysam Mireshghi; Mohsen Zaeferani; Mehrbod Ghasempour
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

2.  Chorioretinectomy for perforating or severe intraocular foreign body injuries.

Authors:  Eric D Weichel; Kraig S Bower; Marcus H Colyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-22       Impact factor: 3.117

3.  Surgical Management of Traumatic Retinal Detachment with Primary Vitrectomy in Adult Patients.

Authors:  Katarzyna Nowomiejska; Tomasz Choragiewicz; Dorota Borowicz; Agnieszka Brzozowska; Joanna Moneta-Wielgos; Ryszard Maciejewski; Anselm G Jünemann; Robert Rejdak
Journal:  J Ophthalmol       Date:  2017-01-09       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.